Blog Article
Ireland remains one of the world's most concentrated MedTech hubs, home to nine of the world's top ten MedTech companies' operations. It boasts a steady pipeline of homegrown innovators graduating from spin-out to commercial-stage and, increasingly, to acquisition. We have collected 12 exciting Irish MedTech companies worth watching right now, from smaller innovators pursuing regulatory approval, so Series C-stage device makers and fresh exits.
1. FIRE1 (Dublin)
Founded by Dr. Conor Hanley and originally incubated at The Foundry in Silicon Valley before relocating to Dublin, FIRE1 develops Norm, an implantable sensor system that monitors fluid levels in heart failure patients to help keep them out of hospital. The company closed a $120M round in January 2025 backed by Medtronic, Novo Holdings and others, bringing total funding to over $210M, and holds FDA Breakthrough Device Designation as it runs its pivotal US trial.
2. Ceroflo (Galway)
Ceroflo is tackling intracranial atherosclerotic disease (ICAD), a leading and under-treated cause of stroke. Its SubMax Stent is heading into first-in-human trials backed by a team with deep roots in Ireland's stroke-device community, including Neuravi alumni. The company raised €6.4M in 2024 and secured a further €5M via EIIS in early 2025, and just this June appointed a new Chief Clinical and Regulatory Officer as it pushes toward US and Japanese regulatory studies.
3. Loci Orthopaedics (Galway)
A University of Galway spin-out, Loci Orthopaedics is developing the InDx Implant System, a clinically evidence-based implant for thumb base joint (CMC) arthritis, a condition with few good surgical options today. In July 2024 the company closed an oversubscribed €12.8M Series A: the largest orthopaedic raise ever for an indigenous Irish start-up. It was led by Seroba and Johnson & Johnson Innovation (JJDC), bringing total funding to over €22M as it pushes through clinical programmes toward US and EU regulatory submissions.
4. LaNua Medical (Dublin/Galway)
A 2024 UCD spin-out founded by interventional radiologist Dr Cormac Farrelly and ex-Medtronic VP Tom Fitzmaurice, LaNua is developing Ecore, a next-generation embolisation device targeting internal bleeding, vascular malformations and tumours. The company raised €6M in seed funding from Elkstone and Atlantic Bridge, then landed a further €6M in DTIF funding in late 2025 for a joint project with Integer and UCD, and is targeting a 2027 launch and US market entry.
5. Deciphex (Dublin)
Deciphex builds AI-powered digital pathology platforms: Diagnexia for clinical diagnostics and Patholytix for pharma preclinical research. They are used to speed up slide review and ease the global pathologist shortage. It's scaled fast: a €31M Series C in January 2025, a further €15M in venture debt in late 2025, and roughly 186 employees as of mid-2026, making it one of the most capital-backed Irish MedTech scale-ups on this list.
6. Aerogen (Galway)
Founded in 1997 and still Irish-headquartered and independent, Aerogen is the global leader in acute-care aerosol drug delivery. Its vibrating-mesh nebuliser technology (Aerogen Solo, Ultra, Pro) is used with ventilators in hospitals across more than 80 countries. It picked up the 2026 AmCham US-Ireland Business Award for Global Impact, and remains one of the best examples of a scaled, hospital-facing Irish hardware company that never needed to leave.
7. X-Bolt Orthopaedics (Dublin)
Founded by orthopaedic surgeon Brian Thornes, X-Bolt makes an expanding-bolt hip fracture and long-bone trauma fixation system designed for better anchorage in osteoporotic bone. The company picked up Orthopedics This Week's Best Technology in Spine award in 2024/2025 and continues to expand its regulatory footprint, including US 510(k) clearance for its Pro-X1 Trochanteric Nail.
We spoke with X-Bolt's Phil Kemp on the GS MedTech Podcast about the journey of building the device - listen here.
8. Versono Medical (Galway)
An endovascular surgery specialist based in Galway, part of the west-of-Ireland vascular device cluster that has already produced exits like Neuravi. Versono is developing an intravascular ultrasonic platform (Fastwire) to treat critical limb ischaemia and complex coronary blockages, and has continued to expand its Galway labs and win grant funding for its VascuSense programme.
9. NUA Surgical (Galway)
NUA Surgical is developing device-based solutions in obstetrics and gynaecology, an area with historically limited device innovation. Its SteriCISION C-section retractor is heading toward US regulatory approval and a 2026 market launch, backed by investors including EQT Life Sciences, with the company recently adding a new non-executive chairwoman to its board.
10. CergenX (Cork/Dublin)
CergenX applies AI to neonatal brain monitoring via its CergenX Wave device, aiming to let clinicians without specialist neurology training screen infants for brain injury at the bedside in around 15 minutes. It was named among Ireland's "hottest start-ups to watch in 2026" and continues to run clinical evaluation studies through Health Innovation Hub Ireland.
11. Neuromod Devices (Dublin)
Neuromod makes Lenire, a bimodal neuromodulation device combining sound and mild tongue stimulation to treat tinnitus: the first and only FDA-approved device of its kind. Off the back of a €10M Series B extension in March 2025 and MDSAP/EU MDR certification in September 2025, Neuromod has been rapidly expanding clinic access across Europe and, as of a February 2026 announcement, into Canada and Australia, creating 25 new roles in Ireland to support it.
12. Wellola (Dublin)
Founded in 2016 by physiotherapist Sonia Neary and Dr Greg Martin, Wellola built Portasana, a patient engagement and communication platform used by NHS trusts and Irish/UK healthcare providers to cut missed appointments and support hospital-at-home care. In March 2026, Wellola joined UK digital health company Mayden to deepen its NHS reach: a growth-through-acquisition story worth noting.
